CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Grant or award | +6,211 | 70,232 | ||
| 2025-02-12 | LEIDEN JEFFREY M Executive Chairman | Grant or award | +7,209 | 32,617 | ||
| 2025-02-12 | Sachdev Amit EVP Chief Patient & Ext Af Off | Grant or award | +6,211 | 76,802 | ||
| 2025-02-12 | Kewalramani Reshma CEO & President | Grant or award | +19,015 | 135,933 | ||
| 2025-02-12 | Bozic Carmen EVP and CMO | Grant or award | +5,546 | 42,853 | ||
| 2025-02-12 | Biller Jonathan EVP and Chief Legal Officer | Grant or award | +4,437 | 20,767 | ||
| 2025-02-12 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Grant or award | +6,211 | 29,436 | ||
| 2025-02-12 | Arbuckle Stuart A EVP, COO | Grant or award | +7,903 | 77,446 | ||
| 2025-02-12 | Ambrose Kristen SVP & Chief Accounting Officer | Grant or award | +2,080 | 12,033 | ||
| 2025-02-12 | ALTSHULER DAVID EVP, Chief Scientific Officer | Grant or award | +5,324 | 48,423 | ||
| 2025-02-11 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale 10b5-1 | −310 | $459.83 | $143K | 64,021 |
| 2025-02-11 | Biller Jonathan EVP and Chief Legal Officer | Sale 10b5-1 | −3,433 | $459.87 | $1.6M | 16,330 |
| 2025-02-11 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Sale 10b5-1 | −1,747 | $459.83 | $803K | 23,225 |
| 2025-02-11 | Ambrose Kristen SVP & Chief Accounting Officer | Sale 10b5-1 | −1,376 | $459.83 | $633K | 9,953 |
| 2025-02-10 | WAGNER CHARLES F JR EVP & Chief Financial Officer | Shares withheld for taxes | −2,649 | $467.98 | $1.2M | 58,879 |
| 2025-02-10 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Shares withheld for taxes 10b5-1 | −2,143 | $467.98 | $1.0M | 64,331 |
| 2025-02-10 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes | −2,056 | $467.98 | $962K | 70,591 |
| 2025-02-10 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −8,300 | $467.98 | $3.9M | 116,918 |
| 2025-02-10 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −2,142 | $467.98 | $1.0M | 37,307 |
| 2025-02-10 | Biller Jonathan EVP and Chief Legal Officer | Shares withheld for taxes 10b5-1 | −1,632 | $467.98 | $764K | 19,763 |
Page 16 of 18 · 344 trades